Researcher Criticizes FDA's Exaggeration Of Plasma's Efficacy In COVID-19 Treatment

NPR's Ari Shapiro talks with Dr. Eric Topol of the Scripps Research Translational Institute about his concerns about the use of convalescent plasma for COVID-19 treatment.